Conference Reports for NATAP

EASL - European Association for the Study of the Liver Barcelona, Spain May 27-30, 2026 Back

LONG-TERM VIROLOGICAL AND CLINICAL OUTCOMES IN PATIENTS WITH HDV-RELATED CIRRHOSIS TREATED WITH BULEVIRTIDE MONOTHERAPY FOR UP TO 4 YEARS (SAVE-D STUDY) better resolution       EASL 2026 May 26-30 Barcelona